Funding for this research was provided by:
the project Genomics Platform Construction for Chinese Major Brain Disease-AVM (PXM2019_026280_000002-AVM)
Received: 20 December 2021
Accepted: 11 May 2022
First Online: 2 June 2022
: This study was approved by the institutional review board of Beijing Tiantan Hospital, Capital Medical University (KY2017-035-02).
: All the participants provided written informed consent.
: The authors declare that they have no competing interests.